co-presented by
ASSOCIATE SPONSORS
co-presented by
ASSOCIATE SPONSORS
Aequs IPO GMP: The Rs 922-crore IPO received bids for over 427 crore shares, as against the offer size of 4.20 crore shares.
Moore Threads' share frenzy stands out in an otherwise sluggish market, signaling strong investor appetite in specific sectors like this year’s AI winners.
Exato Technologies stock market debut was at par with the grey market expectations, which had anticipated strong listing gains for the issue.
Meesho, Aequs, Vidya Wires IPO shares are scheduled to be listed on NSE and BSE on December 10, while allotment is likely to be finalised on December 8.
Park Medi World has reduced its IPO size from Rs 1,260 crore planned earlier as per the DRHP, which was comprised of fresh issue of Rs 960 crore worth shares, and an offer-for-sale of Rs 300 crore.
Platforms tracking unofficial market activity pegged the grey market premium (GMP) for both issues as high as 31 percent.
The company is informally speaking with banks to prepare a prospectus that they plan to file with the regulator as soon as possible, the people said, asking not to be identified.
This will be the second InvIT from NHAI, which operates a private InvIT, National Highways Infra Trust, which is anchored by global investors CPP Investments and Ontario Teachers’ Pension Plan
While the outsized allocation to SBI MF triggered walkouts by global and domestic giants, data shows the anchor stakes were too small to meaningfully move fund performance
Vidya Wires IPO GMP: Vidya Wires launched its IPO to raise over Rs 300 crore at a price band of Rs 48-52 per share
Aequs IPO share allotment is likely to be finalised on December 8, while share listing is scheduled to take place on December 10.
Meesho IPO GMP: While the GMP has slightly fallen recently, it still indicates a strong listing for the e-commerce platform.
Geojit Financial Services, has come out with its report on Aequs Ltd. The research firm has recommended to “ Subscribe” the ipo in its research report as on December 03, 2025.
Geojit Financial Services, has come out with its report on Meesho Ltd. The research firm has recommended to “ Subscribe” the ipo in its research report as on December 03, 2025.
Corona Remedies IPO | The company has revised its IPO size to Rs 655.37 crore, lower than the Rs 800 crore initially planned at the time of submitting draft papers in late April.
Nephrocare Health Services IPO | The company aims to raise Rs 353.4 crore by issuing fresh shares, while promoters and investors will be selling up to 1.12 crore equity shares via offer-for-sale.
Shares of both the issues will be listed on the stock exchanges on December 15.
Ajcon Global, has come out with its report on Meesho Ltd. The research firm has recommended to “ Subscribe” the ipo in its research report as on December 03, 2025.
Ajcon Global, has come out with its report on Aequs Ltd. The research firm has recommended to “ Subscribe” the ipo in its research report as on December 02, 2025.
Deven Choksey, has come out with its report on Aequs Ltd. The research firm has recommended to “ Subscribe” the ipo in its research report as on December 02, 2025.
Anand Rathi, has come out with its report on Aequs Ltd. The research firm has recommended to “ Subscribe” the ipo in its research report as on December 02, 2025.
Vidya Wires shares are expected to be allotted on December 8, while the shares will be listed on the BSE and NSE on December 10.
Anand Rathi, has come out with its report on Meesho Ltd. The research firm has recommended to “ Subscribe” the ipo in its research report as on December 02, 2025.
As of the latest data, the retail quota stands subscribed at 1.16 times, while non-institutional investors have bid 0.38 times their allotted portion.
Disproportionate anchor allotments to SBI MF ignites debate over fairness, transparency and the the relevance of 'anchor' as several large funds opt out of the issue
